Global Second-Generation Antipsychotics Market Research Report 2025

Second-Generation Antipsychotics Market

Second-generation antipsychotics, also known as atypical antipsychotics or novel antipsychotics. Compared with the first generation drugs, the second generation antipsychotic drugs have significant differences in pharmacological mechanisms, clinical efficacy, and side effect profiles, making them the mainstream choice for the treatment of severe mental disorders such as schizophrenia and bipolar disorder. From the perspective of pharmacological mechanisms, second-generation antipsychotics can be divided into four categories: 5-hydroxytryptamine and dopamine receptor antagonists (such as risperidone, olanzapine, quetiapine, and ziprasidone), multi receptor acting drugs (such as clozapine), selective dopamine receptor antagonists (such as amisulpride), and dopamine receptor partial agonists (such as aripiprazole).

The global market for second-generation antipsychotics has shown a growth trend in recent years. Core products such as olanzapine, quetiapine, and risperidone have long dominated sales, while relatively new drugs such as aripiprazole and ziprasidone have also shown good growth momentum. The main driving factors of the market include the increasing burden of mental illness, changes in treatment concepts, increased policy support, and breakthroughs in research and development innovation. The market has significant regional differences. Currently, North America holds the largest market share, with multinational pharmaceutical giants such as Pfizer, Eli Lilly, Novartis, and Merck dominating the market. The European market follows closely behind, with a slightly slower growth rate than North America, but the competitive landscape is more fragmented with numerous participants. In the Asia Pacific region, the Japanese market is relatively small and growing slowly, dominated by several large local pharmaceutical companies. The Chinese and Indian markets are not large in scale, but their growth rates are significantly higher than the global average, making them key regions for global pharmaceutical companies to layout. In the future, market differentiation will intensify, and original drugs with expired patents will face fierce competition from generic drugs, resulting in a significant decrease in prices, while new mechanism drugs with significant clinical advantages can gain premium space. Early intervention for mental illness will receive more attention, and the demand for low-dose formulations and drugs with fewer side effects suitable for early intervention will increase. Digital health technologies such as electronic prescriptions, telemedicine, and medication compliance monitoring will be deeply integrated with antipsychotic drug treatment. Emerging economies such as China and India will become important engines of global growth. With the improvement of medical infrastructure and increased payment capacity, the demand for high-quality antipsychotic drugs will rapidly grow, providing strategic opportunities for global pharmaceutical companies.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Second-Generation Antipsychotics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Second-Generation Antipsychotics.

The Second-Generation Antipsychotics market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Second-Generation Antipsychotics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Second-Generation Antipsychotics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Second-Generation Antipsychotics Market Report

Core Chapters

1.1 Product Definition

1.2 Second-Generation Antipsychotics by Type

1.2.1 Global Second-Generation Antipsychotics Market Value Comparison by Type (2024 VS 2031)

1.2.2 5-Hydroxytryptamine And Dopamine Receptor Antagonists

1.2.3 Multi Receptor Acting Drugs

1.2.4 Selective Dopamine Receptor Antagonists

1.2.5 Dopamine Receptor Partial Agonists

1.3 Second-Generation Antipsychotics by Application

1.3.1 Global Second-Generation Antipsychotics Market Value by Application (2024 VS 2031)

1.3.2 Schizophrenia

1.3.3 Bipolar Disorder

1.3.4 Adjuvant Treatment For Depression

1.3.5 Other Mental Illnesses

1.4 Global Second-Generation Antipsychotics Market Size Estimates and Forecasts

1.4.1 Global Second-Generation Antipsychotics Revenue 2020-2031

1.4.2 Global Second-Generation Antipsychotics Sales 2020-2031

1.4.3 Global Second-Generation Antipsychotics Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2.1 Global Second-Generation Antipsychotics Sales Market Share by Manufacturers (2020-2025)

2.2 Global Second-Generation Antipsychotics Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Second-Generation Antipsychotics Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Second-Generation Antipsychotics, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Second-Generation Antipsychotics, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Second-Generation Antipsychotics, Product Type & Application

2.7 Global Key Manufacturers of Second-Generation Antipsychotics, Date of Enter into This Industry

2.8 Global Second-Generation Antipsychotics Market Competitive Situation and Trends

2.8.1 Global Second-Generation Antipsychotics Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Second-Generation Antipsychotics Players Market Share by Revenue

2.8.3 Global Second-Generation Antipsychotics Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Second-Generation Antipsychotics Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Second-Generation Antipsychotics Sales by Region: 2020-2031

3.2.1 Global Second-Generation Antipsychotics Sales by Region: 2020-2025

3.2.2 Global Second-Generation Antipsychotics Sales by Region: 2026-2031

3.3 Global Second-Generation Antipsychotics Revenue by Region: 2020-2031

3.3.1 Global Second-Generation Antipsychotics Revenue by Region: 2020-2025

3.3.2 Global Second-Generation Antipsychotics Revenue by Region: 2026-2031

3.4 North America Second-Generation Antipsychotics Market Facts & Figures by Country

3.4.1 North America Second-Generation Antipsychotics Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Second-Generation Antipsychotics Sales by Country (2020-2031)

3.4.3 North America Second-Generation Antipsychotics Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Second-Generation Antipsychotics Market Facts & Figures by Country

3.5.1 Europe Second-Generation Antipsychotics Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Second-Generation Antipsychotics Sales by Country (2020-2031)

3.5.3 Europe Second-Generation Antipsychotics Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Second-Generation Antipsychotics Market Facts & Figures by Region

3.6.1 Asia Pacific Second-Generation Antipsychotics Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Second-Generation Antipsychotics Sales by Region (2020-2031)

3.6.3 Asia Pacific Second-Generation Antipsychotics Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Second-Generation Antipsychotics Market Facts & Figures by Country

3.7.1 Latin America Second-Generation Antipsychotics Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Second-Generation Antipsychotics Sales by Country (2020-2031)

3.7.3 Latin America Second-Generation Antipsychotics Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Second-Generation Antipsychotics Market Facts & Figures by Country

3.8.1 Middle East and Africa Second-Generation Antipsychotics Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Second-Generation Antipsychotics Sales by Country (2020-2031)

3.8.3 Middle East and Africa Second-Generation Antipsychotics Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Second-Generation Antipsychotics Sales by Type (2020-2031)

4.1.1 Global Second-Generation Antipsychotics Sales by Type (2020-2025)

4.1.2 Global Second-Generation Antipsychotics Sales by Type (2026-2031)

4.1.3 Global Second-Generation Antipsychotics Sales Market Share by Type (2020-2031)

4.2 Global Second-Generation Antipsychotics Revenue by Type (2020-2031)

4.2.1 Global Second-Generation Antipsychotics Revenue by Type (2020-2025)

4.2.2 Global Second-Generation Antipsychotics Revenue by Type (2026-2031)

4.2.3 Global Second-Generation Antipsychotics Revenue Market Share by Type (2020-2031)

4.3 Global Second-Generation Antipsychotics Price by Type (2020-2031)

5.1 Global Second-Generation Antipsychotics Sales by Application (2020-2031)

5.1.1 Global Second-Generation Antipsychotics Sales by Application (2020-2025)

5.1.2 Global Second-Generation Antipsychotics Sales by Application (2026-2031)

5.1.3 Global Second-Generation Antipsychotics Sales Market Share by Application (2020-2031)

5.2 Global Second-Generation Antipsychotics Revenue by Application (2020-2031)

5.2.1 Global Second-Generation Antipsychotics Revenue by Application (2020-2025)

5.2.2 Global Second-Generation Antipsychotics Revenue by Application (2026-2031)

5.2.3 Global Second-Generation Antipsychotics Revenue Market Share by Application (2020-2031)

5.3 Global Second-Generation Antipsychotics Price by Application (2020-2031)

6.1 Sumitomo Dainippon Pharma

6.1.1 Sumitomo Dainippon Pharma Company Information

6.1.2 Sumitomo Dainippon Pharma Description and Business Overview

6.1.3 Sumitomo Dainippon Pharma Second-Generation Antipsychotics Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Sumitomo Dainippon Pharma Second-Generation Antipsychotics Product Portfolio

6.1.5 Sumitomo Dainippon Pharma Recent Developments/Updates

6.2 Roche

6.2.1 Roche Company Information

6.2.2 Roche Description and Business Overview

6.2.3 Roche Second-Generation Antipsychotics Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Roche Second-Generation Antipsychotics Product Portfolio

6.2.5 Roche Recent Developments/Updates

6.3 Pfizer

6.3.1 Pfizer Company Information

6.3.2 Pfizer Description and Business Overview

6.3.3 Pfizer Second-Generation Antipsychotics Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Pfizer Second-Generation Antipsychotics Product Portfolio

6.3.5 Pfizer Recent Developments/Updates

6.4 Novartis

6.4.1 Novartis Company Information

6.4.2 Novartis Description and Business Overview

6.4.3 Novartis Second-Generation Antipsychotics Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Novartis Second-Generation Antipsychotics Product Portfolio

6.4.5 Novartis Recent Developments/Updates

6.5 Otsuka Pharmaceutical

6.5.1 Otsuka Pharmaceutical Company Information

6.5.2 Otsuka Pharmaceutical Description and Business Overview

6.5.3 Otsuka Pharmaceutical Second-Generation Antipsychotics Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Otsuka Pharmaceutical Second-Generation Antipsychotics Product Portfolio

6.5.5 Otsuka Pharmaceutical Recent Developments/Updates

6.6 AbbVie

6.6.1 AbbVie Company Information

6.6.2 AbbVie Description and Business Overview

6.6.3 AbbVie Second-Generation Antipsychotics Sales, Revenue and Gross Margin (2020-2025)

6.6.4 AbbVie Second-Generation Antipsychotics Product Portfolio

6.6.5 AbbVie Recent Developments/Updates

6.7 Johnson And Johnson

6.7.1 Johnson And Johnson Company Information

6.7.2 Johnson And Johnson Description and Business Overview

6.7.3 Johnson And Johnson Second-Generation Antipsychotics Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Johnson And Johnson Second-Generation Antipsychotics Product Portfolio

6.7.5 Johnson And Johnson Recent Developments/Updates

6.8 Ipsen

6.8.1 Ipsen Company Information

6.8.2 Ipsen Description and Business Overview

6.8.3 Ipsen Second-Generation Antipsychotics Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Ipsen Second-Generation Antipsychotics Product Portfolio

6.8.5 Ipsen Recent Developments/Updates

6.9 Merck

6.9.1 Merck Company Information

6.9.2 Merck Description and Business Overview

6.9.3 Merck Second-Generation Antipsychotics Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Merck Second-Generation Antipsychotics Product Portfolio

6.9.5 Merck Recent Developments/Updates

6.10 Eli Lilly

6.10.1 Eli Lilly Company Information

6.10.2 Eli Lilly Description and Business Overview

6.10.3 Eli Lilly Second-Generation Antipsychotics Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Eli Lilly Second-Generation Antipsychotics Product Portfolio

6.10.5 Eli Lilly Recent Developments/Updates

6.11 Luye Pharma Group

6.11.1 Luye Pharma Group Company Information

6.11.2 Luye Pharma Group Description and Business Overview

6.11.3 Luye Pharma Group Second-Generation Antipsychotics Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Luye Pharma Group Second-Generation Antipsychotics Product Portfolio

6.11.5 Luye Pharma Group Recent Developments/Updates

6.12 Nhwa Pharmaceutical

6.12.1 Nhwa Pharmaceutical Company Information

6.12.2 Nhwa Pharmaceutical Description and Business Overview

6.12.3 Nhwa Pharmaceutical Second-Generation Antipsychotics Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Nhwa Pharmaceutical Second-Generation Antipsychotics Product Portfolio

6.12.5 Nhwa Pharmaceutical Recent Developments/Updates

6.13 Livzon Pharmaceutical Group

6.13.1 Livzon Pharmaceutical Group Company Information

6.13.2 Livzon Pharmaceutical Group Description and Business Overview

6.13.3 Livzon Pharmaceutical Group Second-Generation Antipsychotics Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Livzon Pharmaceutical Group Second-Generation Antipsychotics Product Portfolio

6.13.5 Livzon Pharmaceutical Group Recent Developments/Updates

6.14 Qilu Pharmaceutical

6.14.1 Qilu Pharmaceutical Company Information

6.14.2 Qilu Pharmaceutical Description and Business Overview

6.14.3 Qilu Pharmaceutical Second-Generation Antipsychotics Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Qilu Pharmaceutical Second-Generation Antipsychotics Product Portfolio

6.14.5 Qilu Pharmaceutical Recent Developments/Updates

6.15 CSPC Pharmaceutical Group

6.15.1 CSPC Pharmaceutical Group Company Information

6.15.2 CSPC Pharmaceutical Group Description and Business Overview

6.15.3 CSPC Pharmaceutical Group Second-Generation Antipsychotics Sales, Revenue and Gross Margin (2020-2025)

6.15.4 CSPC Pharmaceutical Group Second-Generation Antipsychotics Product Portfolio

6.15.5 CSPC Pharmaceutical Group Recent Developments/Updates

6.16 Chengdu Kanghong Pharmaceutical

6.16.1 Chengdu Kanghong Pharmaceutical Company Information

6.16.2 Chengdu Kanghong Pharmaceutical Description and Business Overview

6.16.3 Chengdu Kanghong Pharmaceutical Second-Generation Antipsychotics Sales, Revenue and Gross Margin (2020-2025)

6.16.4 Chengdu Kanghong Pharmaceutical Second-Generation Antipsychotics Product Portfolio

6.16.5 Chengdu Kanghong Pharmaceutical Recent Developments/Updates

6.17 Hansoh Pharma

6.17.1 Hansoh Pharma Company Information

6.17.2 Hansoh Pharma Description and Business Overview

6.17.3 Hansoh Pharma Second-Generation Antipsychotics Sales, Revenue and Gross Margin (2020-2025)

6.17.4 Hansoh Pharma Second-Generation Antipsychotics Product Portfolio

6.17.5 Hansoh Pharma Recent Developments/Updates

6.18 Hisun Pharmaceutical

6.18.1 Hisun Pharmaceutical Company Information

6.18.2 Hisun Pharmaceutical Description and Business Overview

6.18.3 Hisun Pharmaceutical Second-Generation Antipsychotics Sales, Revenue and Gross Margin (2020-2025)

6.18.4 Hisun Pharmaceutical Second-Generation Antipsychotics Product Portfolio

6.18.5 Hisun Pharmaceutical Recent Developments/Updates

6.19 Chia Tai Tianqing Pharmaceutical

6.19.1 Chia Tai Tianqing Pharmaceutical Company Information

6.19.2 Chia Tai Tianqing Pharmaceutical Description and Business Overview

6.19.3 Chia Tai Tianqing Pharmaceutical Second-Generation Antipsychotics Sales, Revenue and Gross Margin (2020-2025)

6.19.4 Chia Tai Tianqing Pharmaceutical Second-Generation Antipsychotics Product Portfolio

6.19.5 Chia Tai Tianqing Pharmaceutical Recent Developments/Updates

6.20 Yangtze River Pharmaceutical Group

6.20.1 Yangtze River Pharmaceutical Group Company Information

6.20.2 Yangtze River Pharmaceutical Group Description and Business Overview

6.20.3 Yangtze River Pharmaceutical Group Second-Generation Antipsychotics Sales, Revenue and Gross Margin (2020-2025)

6.20.4 Yangtze River Pharmaceutical Group Second-Generation Antipsychotics Product Portfolio

6.20.5 Yangtze River Pharmaceutical Group Recent Developments/Updates

7.1 Second-Generation Antipsychotics Industry Chain Analysis

7.2 Second-Generation Antipsychotics Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Second-Generation Antipsychotics Production Mode & Process Analysis

7.4 Second-Generation Antipsychotics Sales and Marketing

7.4.1 Second-Generation Antipsychotics Sales Channels

7.4.2 Second-Generation Antipsychotics Distributors

7.5 Second-Generation Antipsychotics Customer Analysis

8.1 Second-Generation Antipsychotics Industry Trends

8.2 Second-Generation Antipsychotics Market Drivers

8.3 Second-Generation Antipsychotics Market Challenges

8.4 Second-Generation Antipsychotics Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

 Table 1. Global Second-Generation Antipsychotics Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

 Table 2. Global Second-Generation Antipsychotics Market Value by Application (2024 VS 2031) & (US$ Million)

 Table 3. Global Second-Generation Antipsychotics Market Competitive Situation by Manufacturers in 2024

 Table 4. Global Second-Generation Antipsychotics Sales (Units) of Key Manufacturers (2020-2025)

 Table 5. Global Second-Generation Antipsychotics Sales Market Share by Manufacturers (2020-2025)

 Table 6. Global Second-Generation Antipsychotics Revenue (US$ Million) by Manufacturers (2020-2025)

 Table 7. Global Second-Generation Antipsychotics Revenue Share by Manufacturers (2020-2025)

 Table 8. Global Market Second-Generation Antipsychotics Average Price (US$/Unit) of Key Manufacturers (2020-2025)

 Table 9. Global Key Players of Second-Generation Antipsychotics, Industry Ranking, 2022 VS 2023 VS 2024

 Table 10. Global Key Manufacturers of Second-Generation Antipsychotics, Manufacturing Sites & Headquarters

 Table 11. Global Key Manufacturers of Second-Generation Antipsychotics, Product Type & Application

 Table 12. Global Key Manufacturers of Second-Generation Antipsychotics, Date of Enter into This Industry

 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

 Table 14. Global Second-Generation Antipsychotics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Second-Generation Antipsychotics as of 2024)

 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

 Table 16. Global Second-Generation Antipsychotics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

 Table 17. Global Second-Generation Antipsychotics Sales by Region (2020-2025) & (Units)

 Table 18. Global Second-Generation Antipsychotics Sales Market Share by Region (2020-2025)

 Table 19. Global Second-Generation Antipsychotics Sales by Region (2026-2031) & (Units)

 Table 20. Global Second-Generation Antipsychotics Sales Market Share by Region (2026-2031)

 Table 21. Global Second-Generation Antipsychotics Revenue by Region (2020-2025) & (US$ Million)

 Table 22. Global Second-Generation Antipsychotics Revenue Market Share by Region (2020-2025)

 Table 23. Global Second-Generation Antipsychotics Revenue by Region (2026-2031) & (US$ Million)

 Table 24. Global Second-Generation Antipsychotics Revenue Market Share by Region (2026-2031)

 Table 25. North America Second-Generation Antipsychotics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

 Table 26. North America Second-Generation Antipsychotics Sales by Country (2020-2025) & (Units)

 Table 27. North America Second-Generation Antipsychotics Sales by Country (2026-2031) & (Units)

 Table 28. North America Second-Generation Antipsychotics Revenue by Country (2020-2025) & (US$ Million)

 Table 29. North America Second-Generation Antipsychotics Revenue by Country (2026-2031) & (US$ Million)

 Table 30. Europe Second-Generation Antipsychotics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

 Table 31. Europe Second-Generation Antipsychotics Sales by Country (2020-2025) & (Units)

 Table 32. Europe Second-Generation Antipsychotics Sales by Country (2026-2031) & (Units)

 Table 33. Europe Second-Generation Antipsychotics Revenue by Country (2020-2025) & (US$ Million)

 Table 34. Europe Second-Generation Antipsychotics Revenue by Country (2026-2031) & (US$ Million)

 Table 35. Asia Pacific Second-Generation Antipsychotics Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

 Table 36. Asia Pacific Second-Generation Antipsychotics Sales by Region (2020-2025) & (Units)

 Table 37. Asia Pacific Second-Generation Antipsychotics Sales by Region (2026-2031) & (Units)

 Table 38. Asia Pacific Second-Generation Antipsychotics Revenue by Region (2020-2025) & (US$ Million)

 Table 39. Asia Pacific Second-Generation Antipsychotics Revenue by Region (2026-2031) & (US$ Million)

 Table 40. Latin America Second-Generation Antipsychotics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

 Table 41. Latin America Second-Generation Antipsychotics Sales by Country (2020-2025) & (Units)

 Table 42. Latin America Second-Generation Antipsychotics Sales by Country (2026-2031) & (Units)

 Table 43. Latin America Second-Generation Antipsychotics Revenue by Country (2020-2025) & (US$ Million)

 Table 44. Latin America Second-Generation Antipsychotics Revenue by Country (2026-2031) & (US$ Million)

 Table 45. Middle East and Africa Second-Generation Antipsychotics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

 Table 46. Middle East and Africa Second-Generation Antipsychotics Sales by Country (2020-2025) & (Units)

 Table 47. Middle East and Africa Second-Generation Antipsychotics Sales by Country (2026-2031) & (Units)

 Table 48. Middle East and Africa Second-Generation Antipsychotics Revenue by Country (2020-2025) & (US$ Million)

 Table 49. Middle East and Africa Second-Generation Antipsychotics Revenue by Country (2026-2031) & (US$ Million)

 Table 50. Global Second-Generation Antipsychotics Sales (Units) by Type (2020-2025)

 Table 51. Global Second-Generation Antipsychotics Sales (Units) by Type (2026-2031)

 Table 52. Global Second-Generation Antipsychotics Sales Market Share by Type (2020-2025)

 Table 53. Global Second-Generation Antipsychotics Sales Market Share by Type (2026-2031)

 Table 54. Global Second-Generation Antipsychotics Revenue (US$ Million) by Type (2020-2025)

 Table 55. Global Second-Generation Antipsychotics Revenue (US$ Million) by Type (2026-2031)

 Table 56. Global Second-Generation Antipsychotics Revenue Market Share by Type (2020-2025)

 Table 57. Global Second-Generation Antipsychotics Revenue Market Share by Type (2026-2031)

 Table 58. Global Second-Generation Antipsychotics Price (US$/Unit) by Type (2020-2025)

 Table 59. Global Second-Generation Antipsychotics Price (US$/Unit) by Type (2026-2031)

 Table 60. Global Second-Generation Antipsychotics Sales (Units) by Application (2020-2025)

 Table 61. Global Second-Generation Antipsychotics Sales (Units) by Application (2026-2031)

 Table 62. Global Second-Generation Antipsychotics Sales Market Share by Application (2020-2025)

 Table 63. Global Second-Generation Antipsychotics Sales Market Share by Application (2026-2031)

 Table 64. Global Second-Generation Antipsychotics Revenue (US$ Million) by Application (2020-2025)

 Table 65. Global Second-Generation Antipsychotics Revenue (US$ Million) by Application (2026-2031)

 Table 66. Global Second-Generation Antipsychotics Revenue Market Share by Application (2020-2025)

 Table 67. Global Second-Generation Antipsychotics Revenue Market Share by Application (2026-2031)

 Table 68. Global Second-Generation Antipsychotics Price (US$/Unit) by Application (2020-2025)

 Table 69. Global Second-Generation Antipsychotics Price (US$/Unit) by Application (2026-2031)

 Table 70. Sumitomo Dainippon Pharma Company Information

 Table 71. Sumitomo Dainippon Pharma Description and Business Overview

 Table 72. Sumitomo Dainippon Pharma Second-Generation Antipsychotics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

 Table 73. Sumitomo Dainippon Pharma Second-Generation Antipsychotics Product

 Table 74. Sumitomo Dainippon Pharma Recent Developments/Updates

 Table 75. Roche Company Information

 Table 76. Roche Description and Business Overview

 Table 77. Roche Second-Generation Antipsychotics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

 Table 78. Roche Second-Generation Antipsychotics Product

 Table 79. Roche Recent Developments/Updates

 Table 80. Pfizer Company Information

 Table 81. Pfizer Description and Business Overview

 Table 82. Pfizer Second-Generation Antipsychotics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

 Table 83. Pfizer Second-Generation Antipsychotics Product

 Table 84. Pfizer Recent Developments/Updates

 Table 85. Novartis Company Information

 Table 86. Novartis Description and Business Overview

 Table 87. Novartis Second-Generation Antipsychotics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

 Table 88. Novartis Second-Generation Antipsychotics Product

 Table 89. Novartis Recent Developments/Updates

 Table 90. Otsuka Pharmaceutical Company Information

 Table 91. Otsuka Pharmaceutical Description and Business Overview

 Table 92. Otsuka Pharmaceutical Second-Generation Antipsychotics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

 Table 93. Otsuka Pharmaceutical Second-Generation Antipsychotics Product

 Table 94. Otsuka Pharmaceutical Recent Developments/Updates

 Table 95. AbbVie Company Information

 Table 96. AbbVie Description and Business Overview

 Table 97. AbbVie Second-Generation Antipsychotics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

 Table 98. AbbVie Second-Generation Antipsychotics Product

 Table 99. AbbVie Recent Developments/Updates

 Table 100. Johnson And Johnson Company Information

 Table 101. Johnson And Johnson Description and Business Overview

 Table 102. Johnson And Johnson Second-Generation Antipsychotics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

 Table 103. Johnson And Johnson Second-Generation Antipsychotics Product

 Table 104. Johnson And Johnson Recent Developments/Updates

 Table 105. Ipsen Company Information

 Table 106. Ipsen Description and Business Overview

 Table 107. Ipsen Second-Generation Antipsychotics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

 Table 108. Ipsen Second-Generation Antipsychotics Product

 Table 109. Ipsen Recent Developments/Updates

 Table 110. Merck Company Information

 Table 111. Merck Description and Business Overview

 Table 112. Merck Second-Generation Antipsychotics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

 Table 113. Merck Second-Generation Antipsychotics Product

 Table 114. Merck Recent Developments/Updates

 Table 115. Eli Lilly Company Information

 Table 116. Eli Lilly Description and Business Overview

 Table 117. Eli Lilly Second-Generation Antipsychotics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

 Table 118. Eli Lilly Second-Generation Antipsychotics Product

 Table 119. Eli Lilly Recent Developments/Updates

 Table 120. Luye Pharma Group Company Information

 Table 121. Luye Pharma Group Description and Business Overview

 Table 122. Luye Pharma Group Second-Generation Antipsychotics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

 Table 123. Luye Pharma Group Second-Generation Antipsychotics Product

 Table 124. Luye Pharma Group Recent Developments/Updates

 Table 125. Nhwa Pharmaceutical Company Information

 Table 126. Nhwa Pharmaceutical Description and Business Overview

 Table 127. Nhwa Pharmaceutical Second-Generation Antipsychotics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

 Table 128. Nhwa Pharmaceutical Second-Generation Antipsychotics Product

 Table 129. Nhwa Pharmaceutical Recent Developments/Updates

 Table 130. Livzon Pharmaceutical Group Company Information

 Table 131. Livzon Pharmaceutical Group Description and Business Overview

 Table 132. Livzon Pharmaceutical Group Second-Generation Antipsychotics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

 Table 133. Livzon Pharmaceutical Group Second-Generation Antipsychotics Product

 Table 134. Livzon Pharmaceutical Group Recent Developments/Updates

 Table 135. Qilu Pharmaceutical Company Information

 Table 136. Qilu Pharmaceutical Description and Business Overview

 Table 137. Qilu Pharmaceutical Second-Generation Antipsychotics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

 Table 138. Qilu Pharmaceutical Second-Generation Antipsychotics Product

 Table 139. Qilu Pharmaceutical Recent Developments/Updates

 Table 140. CSPC Pharmaceutical Group Company Information

 Table 141. CSPC Pharmaceutical Group Description and Business Overview

 Table 142. CSPC Pharmaceutical Group Second-Generation Antipsychotics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

 Table 143. CSPC Pharmaceutical Group Second-Generation Antipsychotics Product

 Table 144. CSPC Pharmaceutical Group Recent Developments/Updates

 Table 145. Chengdu Kanghong Pharmaceutical Company Information

 Table 146. Chengdu Kanghong Pharmaceutical Description and Business Overview

 Table 147. Chengdu Kanghong Pharmaceutical Second-Generation Antipsychotics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

 Table 148. Chengdu Kanghong Pharmaceutical Second-Generation Antipsychotics Product

 Table 149. Chengdu Kanghong Pharmaceutical Recent Developments/Updates

 Table 150. Hansoh Pharma Company Information

 Table 151. Hansoh Pharma Description and Business Overview

 Table 152. Hansoh Pharma Second-Generation Antipsychotics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

 Table 153. Hansoh Pharma Second-Generation Antipsychotics Product

 Table 154. Hansoh Pharma Recent Developments/Updates

 Table 155. Hisun Pharmaceutical Company Information

 Table 156. Hisun Pharmaceutical Description and Business Overview

 Table 157. Hisun Pharmaceutical Second-Generation Antipsychotics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

 Table 158. Hisun Pharmaceutical Second-Generation Antipsychotics Product

 Table 159. Hisun Pharmaceutical Recent Developments/Updates

 Table 160. Chia Tai Tianqing Pharmaceutical Company Information

 Table 161. Chia Tai Tianqing Pharmaceutical Description and Business Overview

 Table 162. Chia Tai Tianqing Pharmaceutical Second-Generation Antipsychotics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

 Table 163. Chia Tai Tianqing Pharmaceutical Second-Generation Antipsychotics Product

 Table 164. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates

 Table 165. Yangtze River Pharmaceutical Group Company Information

 Table 166. Yangtze River Pharmaceutical Group Description and Business Overview

 Table 167. Yangtze River Pharmaceutical Group Second-Generation Antipsychotics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

 Table 168. Yangtze River Pharmaceutical Group Second-Generation Antipsychotics Product

 Table 169. Yangtze River Pharmaceutical Group Recent Developments/Updates

 Table 170. Key Raw Materials Lists

 Table 171. Raw Materials Key Suppliers Lists

 Table 172. Second-Generation Antipsychotics Distributors List

 Table 173. Second-Generation Antipsychotics Customers List

 Table 174. Second-Generation Antipsychotics Market Trends

 Table 175. Second-Generation Antipsychotics Market Drivers

 Table 176. Second-Generation Antipsychotics Market Challenges

 Table 177. Second-Generation Antipsychotics Market Restraints

 Table 178. Research Programs/Design for This Report

 Table 179. Key Data Information from Secondary Sources

 Table 180. Key Data Information from Primary Sources

 Table 181. Authors List of This Report

List of Figures

 Figure 1. Product Picture of Second-Generation Antipsychotics

 Figure 2. Global Second-Generation Antipsychotics Market Value Comparison by Type (2020-2031) & (US$ Million)

 Figure 3. Global Second-Generation Antipsychotics Market Share by Type: 2024 & 2031

 Figure 4. 5-Hydroxytryptamine And Dopamine Receptor Antagonists Product Picture

 Figure 5. Multi Receptor Acting Drugs Product Picture

 Figure 6. Selective Dopamine Receptor Antagonists Product Picture

 Figure 7. Dopamine Receptor Partial Agonists Product Picture

 Figure 8. Global Second-Generation Antipsychotics Market Value by Application (2020-2031) & (US$ Million)

 Figure 9. Global Second-Generation Antipsychotics Market Share by Application: 2024 & 2031

 Figure 10. Schizophrenia

 Figure 11. Bipolar Disorder

 Figure 12. Adjuvant Treatment For Depression

 Figure 13. Other Mental Illnesses

 Figure 14. Global Second-Generation Antipsychotics Revenue, (US$ Million), 2020 VS 2024 VS 2031

 Figure 15. Global Second-Generation Antipsychotics Market Size (2020-2031) & (US$ Million)

 Figure 16. Global Second-Generation Antipsychotics Sales (2020-2031) & (Units)

 Figure 17. Global Second-Generation Antipsychotics Average Price (US$/Unit) & (2020-2031)

 Figure 18. Second-Generation Antipsychotics Report Years Considered

 Figure 19. Second-Generation Antipsychotics Sales Share by Manufacturers in 2024

 Figure 20. Global Second-Generation Antipsychotics Revenue Share by Manufacturers in 2024

 Figure 21. Global 5 and 10 Largest Second-Generation Antipsychotics Players: Market Share by Revenue in Second-Generation Antipsychotics in 2024

 Figure 22. Second-Generation Antipsychotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

 Figure 23. Global Second-Generation Antipsychotics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

 Figure 24. North America Second-Generation Antipsychotics Sales Market Share by Country (2020-2031)

 Figure 25. North America Second-Generation Antipsychotics Revenue Market Share by Country (2020-2031)

 Figure 26. United States Second-Generation Antipsychotics Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 27. Canada Second-Generation Antipsychotics Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 28. Europe Second-Generation Antipsychotics Sales Market Share by Country (2020-2031)

 Figure 29. Europe Second-Generation Antipsychotics Revenue Market Share by Country (2020-2031)

 Figure 30. Germany Second-Generation Antipsychotics Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 31. France Second-Generation Antipsychotics Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 32. U.K. Second-Generation Antipsychotics Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 33. Italy Second-Generation Antipsychotics Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 34. Russia Second-Generation Antipsychotics Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 35. Asia Pacific Second-Generation Antipsychotics Sales Market Share by Region (2020-2031)

 Figure 36. Asia Pacific Second-Generation Antipsychotics Revenue Market Share by Region (2020-2031)

 Figure 37. China Second-Generation Antipsychotics Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 38. Japan Second-Generation Antipsychotics Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 39. South Korea Second-Generation Antipsychotics Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 40. India Second-Generation Antipsychotics Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 41. Australia Second-Generation Antipsychotics Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 42. China Taiwan Second-Generation Antipsychotics Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 43. Southeast Asia Second-Generation Antipsychotics Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 44. Latin America Second-Generation Antipsychotics Sales Market Share by Country (2020-2031)

 Figure 45. Latin America Second-Generation Antipsychotics Revenue Market Share by Country (2020-2031)

 Figure 46. Mexico Second-Generation Antipsychotics Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 47. Brazil Second-Generation Antipsychotics Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 48. Argentina Second-Generation Antipsychotics Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 49. Colombia Second-Generation Antipsychotics Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 50. Middle East and Africa Second-Generation Antipsychotics Sales Market Share by Country (2020-2031)

 Figure 51. Middle East and Africa Second-Generation Antipsychotics Revenue Market Share by Country (2020-2031)

 Figure 52. Turkey Second-Generation Antipsychotics Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 53. Saudi Arabia Second-Generation Antipsychotics Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 54. UAE Second-Generation Antipsychotics Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 55. Global Sales Market Share of Second-Generation Antipsychotics by Type (2020-2031)

 Figure 56. Global Revenue Market Share of Second-Generation Antipsychotics by Type (2020-2031)

 Figure 57. Global Second-Generation Antipsychotics Price (US$/Unit) by Type (2020-2031)

 Figure 58. Global Sales Market Share of Second-Generation Antipsychotics by Application (2020-2031)

 Figure 59. Global Revenue Market Share of Second-Generation Antipsychotics by Application (2020-2031)

 Figure 60. Global Second-Generation Antipsychotics Price (US$/Unit) by Application (2020-2031)

 Figure 61. Second-Generation Antipsychotics Value Chain

 Figure 62. Channels of Distribution (Direct Vs Distribution)

 Figure 63. Bottom-up and Top-down Approaches for This Report

 Figure 64. Data Triangulation

 Figure 65. Key Executives Interviewed